PURPLE BIOTECH LTD.(PPBT)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

PURPLE BIOTECH LTD. (PPBT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. PPBT is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $1.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2020), PURPLE BIOTECH LTD. reports quarterly revenue of $1.0M, net income of $28.1M. Top institutional holders of PPBT by reported 13-F value include SmartHarvest Portfolios, HRT FINANCIAL, CITADEL ADVISORS, based on the most recent SEC filings. PPBT trades on the Nasdaq exchange and files with the SEC under CIK 1614744. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PPBT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PURPLE BIOTECH LTD. directly from SEC EDGAR.

Revenue

$1.0M

Net Income

$28.1M

PPBT key financials by period

PURPLE BIOTECH LTD. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202020-F/A$1.0M——
FY 201920-F/A$1.0M——
FY 201820-F$1.0M——
FY 201720-F$100.0K——

Institutions holding PPBT

Institutional investors reporting a position in PURPLE BIOTECH LTD. on SEC Form 13F.
InstitutionSharesValueReported
SmartHarvest Portfolios28,468$47.8K2026-06-30
HRT FINANCIAL14,640$24.0K2026-06-30
CITADEL ADVISORS13,166$22.1K2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP12,847$21.6K2026-06-30
Independent Advisor Alliance11,901$20.0K2026-06-30
SRS Capital Advisors1,453$2.4K2026-06-30
GROUP ONE TRADING, L.P.900$1.5K2026-06-30
RHUMBLINE ADVISERS856$1.4K2026-06-30
UBS Group AG751$1.3K2026-06-30
MORGAN STANLEY197$331.002026-06-30
SEC EDGAR: CIK 1614744 →
PPBT

PURPLE BIOTECH LTD.

PPBT
NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $1.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

FY 2020
EDGAR

$1.00M

Net Income

FY 2020
EDGAR

$28.07M

Top Institutional Holders

as of Q2 2026
$142.7K total
SmartHarvest Portfolios, LLC
$47.8K+57.0%
HRT FINANCIAL LP
$24.0KNew
CITADEL ADVISORS LLC
$22.1KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$21.6K-75.9%
Independent Advisor Alliance
$20.0KNew
SRS Capital Advisors, Inc.
$2.4KNew
GROUP ONE TRADING, L.P.
$1.5K+4400.0%
RHUMBLINE ADVISERS
$1.4K+20.6%
UBS Group AG
$1.3K+658.6%
MORGAN STANLEY
$331-65.9%
Loading ratio trend…